{"id": 936022620721606656, "geo": null, "lang": "en", "text": "RT @stefaniei: Companies racing to bring a new class of migraine drugs to the market show positive trial results https://t.co/EQJ7KEYSTK vi\u2026", "user": {"id": 183626808, "url": "http://t.co/PlXHLByVXo", "lang": "en", "name": "Teva Pharmaceuticals", "id_str": "183626808", "entities": {"url": {"urls": [{"url": "http://t.co/PlXHLByVXo", "indices": [0, 22], "display_url": "tevausa.com", "expanded_url": "http://www.tevausa.com"}]}, "description": {"urls": [{"url": "https://t.co/gsGkRP8J3A", "indices": [136, 159], "display_url": "ow.ly/UZcKg", "expanded_url": "http://ow.ly/UZcKg"}]}}, "location": "United States", "verified": false, "following": true, "protected": false, "time_zone": null, "created_at": "Fri Aug 27 13:45:33 +0000 2010", "utc_offset": null, "description": "Official Teva US Twitter feed. We don't just make medicines, we make a difference in people's lives. Managed by Corp Comms. Guidelines: https://t.co/gsGkRP8J3A", "geo_enabled": false, "screen_name": "TevaUSA", "listed_count": 108, "friends_count": 1167, "is_translator": false, "notifications": false, "statuses_count": 1799, "default_profile": false, "followers_count": 5772, "translator_type": "none", "favourites_count": 855, "profile_image_url": "http://pbs.twimg.com/profile_images/1114240566001315840/wwBtyZu1_normal.png", "profile_banner_url": "https://pbs.twimg.com/profile_banners/183626808/1517338835", "profile_link_color": "94D487", "profile_text_color": "000000", "follow_request_sent": false, "contributors_enabled": false, "has_extended_profile": false, "default_profile_image": false, "is_translation_enabled": false, "profile_background_tile": false, "profile_image_url_https": "https://pbs.twimg.com/profile_images/1114240566001315840/wwBtyZu1_normal.png", "profile_background_color": "94D487", "profile_sidebar_fill_color": "000000", "profile_background_image_url": "http://abs.twimg.com/images/themes/theme1/bg.png", "profile_sidebar_border_color": "000000", "profile_use_background_image": false, "profile_background_image_url_https": "https://abs.twimg.com/images/themes/theme1/bg.png"}, "place": null, "id_str": "936022620721606656", "source": "<a href=\"http://twitter.com/download/iphone\" rel=\"nofollow\">Twitter for iPhone</a>", "entities": {"urls": [{"url": "https://t.co/EQJ7KEYSTK", "indices": [113, 136], "display_url": "wsj.com/articles/new-m\u2026", "expanded_url": "https://www.wsj.com/articles/new-migraine-drugs-show-promise-in-race-to-sell-next-generation-treatments-1511994639"}], "symbols": [], "hashtags": [], "user_mentions": [{"id": 212278192, "name": "Stefanie Ilgenfritz", "id_str": "212278192", "indices": [3, 13], "screen_name": "stefaniei"}]}, "favorited": false, "retweeted": false, "truncated": false, "created_at": "Thu Nov 30 00:02:37 +0000 2017", "coordinates": null, "contributors": null, "retweet_count": 13, "favorite_count": 0, "is_quote_status": false, "retweeted_status": {"id": 936002855349211137, "geo": null, "lang": "en", "text": "Companies racing to bring a new class of migraine drugs to the market show positive trial results\u2026 https://t.co/qwqHTuEToP", "user": {"id": 212278192, "url": "https://t.co/MbHmPfGuLd", "lang": "en", "name": "Stefanie Ilgenfritz", "id_str": "212278192", "entities": {"url": {"urls": [{"url": "https://t.co/MbHmPfGuLd", "indices": [0, 23], "display_url": "WSJ.com", "expanded_url": "http://WSJ.com"}]}, "description": {"urls": []}}, "location": "", "verified": true, "following": false, "protected": false, "time_zone": null, "created_at": "Fri Nov 05 16:49:43 +0000 2010", "utc_offset": null, "description": "Bureau Chief, Health & Science, The Wall Street Journal. University of Michigan and NYU alum. Retweets are not endorsements.", "geo_enabled": false, "screen_name": "stefaniei", "listed_count": 513, "friends_count": 913, "is_translator": false, "notifications": false, "statuses_count": 12131, "default_profile": true, "followers_count": 13026, "translator_type": "none", "favourites_count": 554, "profile_image_url": "http://pbs.twimg.com/profile_images/973931212225073152/o0uB29ck_normal.jpg", "profile_banner_url": "https://pbs.twimg.com/profile_banners/212278192/1381929468", "profile_link_color": "1DA1F2", "profile_text_color": "333333", "follow_request_sent": false, "contributors_enabled": false, "has_extended_profile": false, "default_profile_image": false, "is_translation_enabled": false, "profile_background_tile": false, "profile_image_url_https": "https://pbs.twimg.com/profile_images/973931212225073152/o0uB29ck_normal.jpg", "profile_background_color": "C0DEED", "profile_sidebar_fill_color": "DDEEF6", "profile_background_image_url": "http://abs.twimg.com/images/themes/theme1/bg.png", "profile_sidebar_border_color": "C0DEED", "profile_use_background_image": true, "profile_background_image_url_https": "https://abs.twimg.com/images/themes/theme1/bg.png"}, "place": null, "id_str": "936002855349211137", "source": "<a href=\"http://twitter.com\" rel=\"nofollow\">Twitter Web Client</a>", "entities": {"urls": [{"url": "https://t.co/qwqHTuEToP", "indices": [99, 122], "display_url": "twitter.com/i/web/status/9\u2026", "expanded_url": "https://twitter.com/i/web/status/936002855349211137"}], "symbols": [], "hashtags": [], "user_mentions": []}, "favorited": false, "retweeted": false, "truncated": true, "created_at": "Wed Nov 29 22:44:05 +0000 2017", "coordinates": null, "contributors": null, "retweet_count": 13, "favorite_count": 16, "is_quote_status": false, "possibly_sensitive": false, "in_reply_to_user_id": null, "in_reply_to_status_id": null, "in_reply_to_screen_name": null, "in_reply_to_user_id_str": null, "in_reply_to_status_id_str": null}, "possibly_sensitive": false, "in_reply_to_user_id": null, "in_reply_to_status_id": null, "in_reply_to_screen_name": null, "in_reply_to_user_id_str": null, "in_reply_to_status_id_str": null}